SCHEMBL27485248

SCHEMBL27485248

Nc1cccc(C(=O)Nc2ccc(Oc3ccccc3)cc2)c1Cc1ccncc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 6/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ PNLIP P16233 1/20 0.51
▸ FLT1 P17948 2/20 0.51
▸ HTT P42858 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ NPY5R Q15761 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ CYP3A4 P08684 1/20 0.47
▸ MMP13 P45452 1/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ MAPK1 P28482 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27486254 0.90 SMN1; SMN2 (0.53) KDRSMN1; SMN2MAPTHTTLMNA
SCHEMBL27467102 0.85 SMN1; SMN2 (0.54) KDRSMN1; SMN2MAPTHTTLMNA
SCHEMBL27485595 0.85 KDR (0.60) KDRSMN1; SMN2MAPTFLT1NPC1
SCHEMBL27486256 0.84 KDR (0.57) KDRSMN1; SMN2MAPTLMNAALDH1A1
SCHEMBL27609433 0.84 ALDH1A1 (0.52) KDRSMN1; SMN2MAPTFLT1HTT
SCHEMBL27485244 0.83 ALDH1A1 (0.52) KDRSMN1; SMN2MAPTHTTLMNA
SCHEMBL27485596 0.80 KCNK3 (0.49) KDRSMN1; SMN2MAPTFLT1HTT
SCHEMBL27548636 0.79 NAMPT (0.56) KDRSMN1; SMN2MAPTFLT1HTT
SCHEMBL27468045 0.79 KDR (0.44) KDRSMN1; SMN2MAPTFLT1HTT
SCHEMBL5674964 0.78 PNLIP (0.70) SMN1; SMN2PNLIPLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback